Get trade alerts

Dodge & Cox 13F: Adds $124M to The Cigna (CI) Stake

The investment firm added 417,173 shares of The Cigna Group, boosting its holdings to over 11.5 million shares.

By · Published

Reviewed by automated data checks against the source filing. How we make and check alerts

Dodge & Cox added 417,173 shares to its stake in The Cigna Group ($CI), a 3.75% increase, according to a 13F filing with the SEC dated May 14, 2026. It reported 11,555,787 shares worth $3.44 billion at the end of the quarter.

Since the filing, $CI is down 4.4% after 1 week, up 0.2% after 1 month and up 3.7% to date (from the $291.61 close on May 14, 2026).

Find the original: Dodge & Cox 13F filings on SEC EDGAR

CI The Cigna Group
$302.30 +10.14% year to date
Daily close · Oct 16, 2026

Key Points

  • Dodge & Cox increased its investment in The Cigna Group by 417,173 shares, now holding 11,555,787 shares worth about $3.44 billion.
  • The Cigna Group, trading on the NYSE under the ticker CI, has a market cap of about $78.53 billion and a P/E ratio of 11.87.
  • The company offers a dividend yield of 2.12% with an annual rate of $6.24 per share.

Get $CI trade alerts by text

We text you when insiders, Congress or big funds trade $CI. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated The Cigna Group alert may contain errors. Disclosures

Dodge & Cox recently boosted its investment in The Cigna Group (NYSE:CI), adding 417,173 shares. This brings their total holdings to 11,555,787 shares, valued at approximately $3.44 billion, as per the latest Form 13F filing with the SEC. The move represents a 3.75% increase from their previous position.

What Changed in Dodge & Cox's Cigna Position

Dodge & Cox increased its stake in The Cigna Group by 417,173 shares, moving from 11,138,614 shares to 11,555,787 shares. This increase reflects a 3.75% growth in their holdings, now valued at around $3.44 billion.

The Cigna Group Stock Up 8.0%

Shares of NYSE:CI traded near $297.38. The Cigna Group has a market cap of approximately $78.53 billion, with a P/E ratio of 11.87 and a forward P/E of 8.87. The stock's beta is 0.302, indicating lower volatility compared to the market. Over the past year, the stock has ranged between $239.51 and $338.89, with moving averages of $282.08 over 50 days and $281.68 over 200 days. The company maintains a current ratio of 0.818 and a quick ratio of 0.657, with a debt-to-equity ratio of 72.81.

Recent Earnings

In its latest earnings report, The Cigna Group posted revenue of $277.89 billion, with a growth rate of 4.6%. The company's net margin stood at 2.26%, and it achieved a return on equity of 16.27%. The next earnings date is scheduled for July 30, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

C 59/100

Reported Apr 30, 2026

  1. Forward outlook

    6 target raises vs 3 cuts.

  2. EPS & revenue

    EPS missed estimates by 0.7%. Revenue met estimates.

  3. Profit surprise

    EBITDA met by 0 percent. Operating income met by 0 percent.

  4. Pre-earnings setup

    Bar was high, analysts already very bullish.

  5. Analyst signal

    2 downgrades, 6 target raises, 3 target cuts.

  6. Earnings quality

    Gross margin down 0.6 points. Positive free cash flow.

Earnings Call Summary

Cigna delivered strong first quarter results with $68.5 billion in revenue and $7.79 adjusted earnings per share, beating expectations. Specialty and Care Services drove growth at 20 percent earnings increase, while Cigna Healthcare achieved 18 percent year-over-year earnings growth. The company is exiting the individual exchange business at year end and exploring strategic alternatives for eviCore prior authorization service, sharpening focus on core high-growth platforms.

Guidance Management raised full year adjusted earnings per share guidance to at least $30.35, up from prior levels. The company plans continued investments in specialty pharmacy and new rebate-free pharmacy model called Signature, rolling out to external clients in 2028.

Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.

Dividend

The Cigna Group offers a dividend rate of $6.24 per share, resulting in a yield of 2.12%. The dividend payout ratio is 24.36%, showing a conservative approach to dividend distribution.

About The Cigna Group

The Cigna Group, headquartered in Bloomfield, Connecticut, provides insurance and related products and services primarily in the United States. Operating through its Evernorth Health Services and Cigna Healthcare segments, the company offers a wide range of health-related services, including pharmacy benefit management and comprehensive medical plans. Led by CEO David Michael Cordani, Cigna serves a diverse customer base, including individuals, employers, and multinational organizations, through various distribution channels.

Bottom Line

Dodge & Cox's increased investment in The Cigna Group is a noteworthy development for investors tracking institutional moves. The 13F filing provides a backward-looking view of their holdings as of the reporting period, offering insight into their confidence in Cigna's performance. As always, these filings represent past actions and not necessarily current positions.

Related Filing Alerts

Source: Dodge & Cox's 13F filing on $CI (May 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Dodge & Cox 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $CI trade alerts by text